529 related articles for article (PubMed ID: 23218706)
21. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
22. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
23. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
Marmor MF; Carr RE; Easterbrook M; Farjo AA; Mieler WF;
Ophthalmology; 2002 Jul; 109(7):1377-82. PubMed ID: 12093666
[No Abstract] [Full Text] [Related]
24. Missing the bull's eye.
Gilbert ME; Savino PJ
Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
[TBL] [Abstract][Full Text] [Related]
25. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
Vanderzee G; Tassi D
Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
[TBL] [Abstract][Full Text] [Related]
26. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
Kellner U; Renner AB; Tillack H
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
[TBL] [Abstract][Full Text] [Related]
27. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
28. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
29. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
[TBL] [Abstract][Full Text] [Related]
30. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
Chiang E; Jampol LM; Fawzi AA
Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
[No Abstract] [Full Text] [Related]
31. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
[TBL] [Abstract][Full Text] [Related]
32. [Critical review of the new recommendations on screening for hydroxychloroquine retinopathy].
Costedoat-Chalumeau N; Ingster-Moati I; Leroux G; Fardeau C; Benveniste O; Simon C; Bodaghi B; Piette JC
Rev Med Interne; 2012 May; 33(5):265-7. PubMed ID: 22088232
[TBL] [Abstract][Full Text] [Related]
33. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
Adam MK; Covert DJ; Stepien KE; Han DP
Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
[TBL] [Abstract][Full Text] [Related]
34. [Update on recommendations for screening for hydroxychloroquine retinopathy].
Couturier A; Giocanti-Aurégan A; Dupas B; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
J Fr Ophtalmol; 2017 Nov; 40(9):793-800. PubMed ID: 29054477
[TBL] [Abstract][Full Text] [Related]
35. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
Asensio-Sánchez VM
Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
[TBL] [Abstract][Full Text] [Related]
36. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
37. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Wolfe F; Marmor MF
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
[TBL] [Abstract][Full Text] [Related]
38. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
Jeltsch BM; Sarraf D; Madjdpour D; Hanson JVM; Pfiffner FK; Koller S; Berger W; Barthelmes D; Al-Sheikh M
Retin Cases Brief Rep; 2024 May; 18(3):351-354. PubMed ID: 36857194
[TBL] [Abstract][Full Text] [Related]
39. Monitoring patients on antimalarials: where are we now?
Easterbrook M
Can J Ophthalmol; 2012 Dec; 47(6):465-70. PubMed ID: 23217497
[No Abstract] [Full Text] [Related]
40. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.
Lai TY; Ngai JW; Chan WM; Lam DS
Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]